News

November 27, 2021

Tagworks announces completion of investment round

Tagworks announces the completion of an investment round led by Meneldor (The Netherlands), Oost NL (The Netherlands), and a syndicate of high net-worth private investors. The proceeds of the financing will be used for the clinical development of Tagworks' lead program.    
April 6, 2021

Key Patent Covering Click-to-Release Granted in the United States

A key patent that encompasses the therapeutic application scope of the Click-to-Release platform has been granted in the US (US 10,967,069 B2), further strengthening Tagworks’ IP portfolio. The patent titled “BIO-ORTHOGONAL DRUG ACTIVATION”, covers the invention of the pyridazine elimination reaction that underlies the Click-to-Release approach. The patent protects a …
May 27, 2020

Tagworks reports new Click-to-Release reaction

Tagworks reports the development of a new and highly reactive Click-to-Release reaction in the Journal of the American Chemical Society. Great collaboration between Tagworks and SyMO-Chem, Syncom, TU/e , Avipep and Levena. https://pubs.acs.org/doi/abs/10.1021/jacs.0c00531
November 1, 2019

Tagworks wins 2019 World ADC Award for Best Publication

Tagworks is pleased to announce that on the 10th of October, it won the World ADC Award for Best Publication during the 10th World ADC Summit 2019 in San Diego. The World ADC Awards exist to commend excellence across nine categories within antibody-drug conjugate research and development. Tagworks applies its Click-to-Release platform …
October 5, 2019

Meet Tagworks at the World ADC meeting in San Diego

World ADC -  9-11 October 2019 https://worldadc-usa.com
August 21, 2019

Click chemistry targets antibody-drug conjugates for the clinic

Bioorthogonal chemistry, already a workhorse of drug discovery research, prepares for the leap into human testing. Researchers at the Memorial Sloan Kettering Cancer Center in New York are preparing the first test in humans of a new type of diagnostic that combines a radioisotope and antibody via bioorthogonal ‘click’ chemistry. …
June 28, 2019

Tagworks to present the click-cleavable ADC technology at the ACS National Meeting

Tagworks will present the latest developments of their click-cleavable ADC technology at the ACS National Meeting in San Diego, taking place on the 25th-29th August. www.acs.org/content/acs/en/meetings/national-meeting  
June 28, 2019

Tagworks to present at RICT2019 in Nantes

Tagworks will present the latest developments of their click-to-release technology at the 55th International Conference on Medicinal Chemistry - Interfacing Chemical Biology and Drug Discovery - in  Nantes, France, taking place on the 3rd-5th July. www.rict2019.org
November 24, 2018

Tagworks to present at CHAINS

Tagworks will present the click-cleavable ADC technology at the CHAINS meeting in Veldhoven, taking place on the 3rd-5th December. www.nwochains.nl  
July 5, 2018

Tagworks to present at the World ADC meeting in San Diego

Tagworks will present the click-cleavable ADC technology at the Word ADC meeting in San Diego, taking place on the 12th-15st November.http://worldadc-usa.com

Curious about what we do? Get in touch!

Logo-diap

About    Our Technology   Pipeline    Join us    News    Contact

Contact
T +31 85 800 8550
info@tagworkspharma.com

Address
Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra